FDA proposes creating one-page medication sheets to simplify drug information for patients
The agency is now proposing making short medication sheets that summarize basic information including the medication’s name, purpose, safety information, common side effects and directions on how to take it.
•
Jun 4, 2023, 4:54 PM
•
Updated 418 days ago
Share:
More Stories
2:11
Beautiful weekend ahead for New Jersey with sunny skies and warm temperatures
29m ago0:44
Jersey Proud: Goya Gives Day collects 100,000 pounds of food donations
48m ago1:54
Boar’s Head deli meat recalled for potential listeria contamination
52m ago0:46
New Jersey to receive more than $72M to help coastal communities prevent flooding
1h ago1:01
‘It’s a beautiful sport.’ New pickleball courts open in Howell Township
2h ago0:29
Man who pleaded guilty to attacking Jewish men sentenced to 30 years on terror charges
2h ago2:11
Beautiful weekend ahead for New Jersey with sunny skies and warm temperatures
29m ago0:44
Jersey Proud: Goya Gives Day collects 100,000 pounds of food donations
48m ago1:54
Boar’s Head deli meat recalled for potential listeria contamination
52m ago0:46
New Jersey to receive more than $72M to help coastal communities prevent flooding
1h ago1:01
‘It’s a beautiful sport.’ New pickleball courts open in Howell Township
2h ago0:29
Man who pleaded guilty to attacking Jewish men sentenced to 30 years on terror charges
2h agoThe FDA is proposing the creation of one-page medication sheets that simplify drug information for patients.
The FDA says 75% of Americans have trouble taking their medications as directed. Using medication incorrectly contributes to nearly 25% of hospital admissions and approximately 125,000 deaths each year.
Small label prints and overly lengthy medication inserts are believed to contribute to the issue.
The agency is now proposing making short medication sheets that summarize basic information including the medication’s name, purpose, safety information, common side effects and directions on how to take it.
The proposal has yet to be finalized and FDA officials are seeking feedback from the public.
